SWTX SpringWorks Therapeutics
- 36.015
- -1.705-4.52%
SpringWorks Therapeutics News
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cassidy James
SpringWorks Therapeutics | 8-K: Current report
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Edris Badreddin
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hambleton Julie
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Islam Saqib
SpringWorks Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
SpringWorks Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
SpringWorks Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
SpringWorks Therapeutics | 8-K: Current report
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hambleton Julie
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fuhrman Alan
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director LYNCH DANIEL
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lewis-Hall Freda C
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ALBAN CARLOS
SpringWorks Therapeutics | 10-Q: Quarterly report
SpringWorks Therapeutics | 8-K: SpringWorks Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates
SpringWorks Therapeutics | ARS: Annual Report to Security Holders
SpringWorks Therapeutics | DEFA14A: Others
SpringWorks Therapeutics | DEF 14A: Definitive information statements
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ashar Bhavesh
Analysis
Price Target
No Data
